dc.contributor.author
Jiao, Wei
dc.contributor.author
Atwal, Gurnit
dc.contributor.author
Polak, Paz
dc.contributor.author
Karlic, Rosa
dc.contributor.author
Cuppen, Edwin
dc.contributor.author
PCAWG Tumor Subtypes and Clinical Translation Working Group
dc.contributor.author
Danyi, Alexandra
dc.contributor.author
de Ridder, Jeroen
dc.contributor.author
van Herpen, Carla
dc.contributor.author
Lolkema, Martijn P.
dc.contributor.author
Steeghs, Neeltje
dc.contributor.author
Getz, Gad
dc.contributor.author
Morris, Quaid D.
dc.contributor.author
Stein, Lincoln D.
dc.contributor.author
PCAWG Consortium
dc.contributor.author
Deu-Pons, Jordi
dc.contributor.author
Frigola, Joan
dc.contributor.author
González-Pérez, Abel
dc.contributor.author
Muiños, Ferran
dc.contributor.author
Mularoni, Loris
dc.contributor.author
Pich, Oriol
dc.contributor.author
Reyes-Salazar, Iker
dc.contributor.author
Rubio-Perez, Carlota
dc.contributor.author
Sabarinathan, Radhakrishnan
dc.contributor.author
Tamborero, David
dc.contributor.author
Aymerich Gregorio, Marta
dc.contributor.author
Campo Güerri, Elias
dc.contributor.author
López Guillermo, Armando
dc.contributor.author
Gelpi Buchaca, Josep Lluís
dc.contributor.author
Rabionet Janssen, Raquel
dc.date.issued
2024-02-26T15:43:51Z
dc.date.issued
2024-02-26T15:43:51Z
dc.date.issued
2020-02-05
dc.date.issued
2024-02-26T15:43:51Z
dc.identifier
https://hdl.handle.net/2445/208101
dc.description.abstract
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of its clinical behaviour, but in 3% of cases a patient presents with a metastatic tumour and no obvious primary. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, we train a deep learning classifier to predict cancer type based on patterns of somatic passenger mutations detected in whole genome sequencing (WGS) of 2606 tumours representing 24 common cancer types produced by the PCAWG Consortium. Our classifier achieves an accuracy of 91% on held-out tumor samples and 88% and 83% respectively on independent primary and metastatic samples, roughly double the accuracy of trained pathologists when presented with a metastatic tumour without knowledge of the primary. Surprisingly, adding information on driver mutations reduced accuracy. Our results have clinical applicability, underscore how patterns of somatic passenger mutations encode the state of the cell of origin, and can inform future strategies to detect the source of circulating tumour DNA.
dc.format
application/pdf
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/https://doi.org/10.1038/s41467-019-13825-8
dc.relation
Nature Communications, 2020, vol. 11, num.1, p. 1-12
dc.relation
https://doi.org/https://doi.org/10.1038/s41467-019-13825-8
dc.rights
cc-by (c) Jiao, W. et al., 2020
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Fonaments Clínics)
dc.subject
Mutació (Biologia)
dc.subject
Mutation (Biology)
dc.title
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion